Meta-analysis of vascular and neoplastic events associated with tamoxifen
Author:
Publisher
Springer Science and Business Media LLC
Subject
Internal Medicine
Link
http://www.springerlink.com/index/pdf/10.1046/j.1525-1497.2003.20724.x
Reference62 articles.
1. Osborne CK. Tamoxifen in the treatment of breast cancer. N Engl J Med. 1998;339:1609–18.
2. Chlebowski RT. Reducing the risk of breast cancer. N Engl J Med. 1998;343:191–8.
3. Chlebowski RT, Col NF, Winer EP, et al. American Society of Clinical Oncology technology assessment of pharmacologic interventions for breast cancer risk reduction including tamoxifen, raloxifene, and aromatase reduction. J Clin Oncol. 2002;20:3328–43.
4. Anonymous. Tamoxifen for early breast cancer: an overview of the randomized trials. Lancet. 1998;351:1451–67.
5. Hasselblad V, McCrory DC. Meta-analytic tools for medical decision making: a practical guide. Med Decis Making. 1995;15:81–96.
Cited by 307 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Is It Possible to Prevent Nontherapeutic Laparotomies in Breast Cancer Patients With Isolated Adnexal Masses?;The American Surgeon™;2024-07-21
2. Risk of endometrial malignancy in women treated for breast cancer: the BLUSH prediction model – evidence from a comprehensive multicentric retrospective cohort study;Climacteric;2024-07-18
3. Sex and sex steroids as determinants of cardiovascular risk;Steroids;2024-06
4. Real-world data of cardio-oncologic interventions for cardiovascular adverse events with oral oncolytics;Cardio-Oncology;2024-04-09
5. Real-World Data of Cardio-oncologic Interventions for Cardiotoxicity with Oral Oncolytics;2024-01-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3